Calamos Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.9M | Buy |
101,786
+2,864
| +3% | +$308K | 0.46% | 57 |
|
|
2025
Q1 | $9.98M | Sell |
98,922
-56,510
| -36% | -$5.7M | 0.5% | 54 |
|
|
2024
Q4 | $13.9M | Buy |
155,432
+872
| +0.6% | +$77.9K | 0.69% | 30 |
|
|
2024
Q3 | $13M | Buy |
154,560
+24,002
| +18% | +$2.01M | 0.66% | 36 |
|
|
2024
Q2 | $10.1M | Sell |
130,558
-22,838
| -15% | -$1.76M | 0.54% | 46 |
|
|
2024
Q1 | $10.5M | Buy |
153,396
+1,134
| +0.7% | +$77.7K | 0.59% | 44 |
|
|
2023
Q4 | $8.8M | Buy |
152,262
+1,376
| +0.9% | +$79.5K | 0.55% | 52 |
|
|
2023
Q3 | $7.97M | Buy |
150,886
+1,511
| +1% | +$79.8K | 0.6% | 45 |
|
|
2023
Q2 | $8.08M | Buy |
149,375
+2,331
| +2% | +$126K | 0.59% | 41 |
|
|
2023
Q1 | $7.36M | Sell |
147,044
-5,361
| -4% | -$268K | 0.58% | 48 |
|
|
2022
Q4 | $7.05M | Sell |
152,405
-651
| -0.4% | -$30.1K | 0.55% | 52 |
|
|
2022
Q3 | $5.93M | Buy |
153,056
+5,138
| +3% | +$199K | 0.51% | 53 |
|
|
2022
Q2 | $5.51M | Buy |
147,918
+2,919
| +2% | +$109K | 0.49% | 57 |
|
|
2022
Q1 | $6.42M | Buy |
144,999
+4,530
| +3% | +$201K | 0.48% | 53 |
|
|
2021
Q4 | $5.97M | Buy |
140,469
+5,187
| +4% | +$220K | 0.44% | 60 |
|
|
2021
Q3 | $5.87M | Buy |
135,282
+1,681
| +1% | +$72.9K | 0.47% | 57 |
|
|
2021
Q2 | $5.71M | Sell |
133,601
-10,400
| -7% | -$445K | 0.44% | 57 |
|
|
2021
Q1 | $5.57M | Sell |
144,001
-24,659
| -15% | -$953K | 0.46% | 65 |
|
|
2020
Q4 | $6.06M | Buy |
168,660
+1,701
| +1% | +$61.1K | 0.55% | 53 |
|
|
2020
Q3 | $6.38M | Buy |
166,959
+33,085
| +25% | +$1.26M | 0.73% | 34 |
|
|
2020
Q2 | $4.7M | Buy |
133,874
+14,034
| +12% | +$493K | 0.59% | 46 |
|
|
2020
Q1 | $3.91M | Buy |
+119,840
| New | +$3.91M | 0.6% | 48 |
|